Concepedia

Giuseppe Privitera

GP

Statistics

Publications

8

Citations

454

H-Index

8

Active since

2019

Affiliations

Università Cattolica del Sacro Cuore(Current)

University of Padua

Istituti di Ricovero e Cura a Carattere Scientifico

Agostino Gemelli University Polyclinic

Aziende Socio Sanitaria Territoriale Rhodense

Giuseppe Privitera is an author at Università Cattolica del Sacro Cuore specializing in inflammatory bowel disease therapy, inflammatory bowel disease, and inflammation.

ORCID

Publications per year

2019–2024

8

Publications

8

GSDMB is increased in IBD and regulates epithelial restitution/repair independent of pyroptosis

Nitish Rana, Giuseppe Privitera, Hannah Kondolf et al. · Cell · 2022 · 218 citations · Full text

, , +9

Dual Targeted Therapy: A Possible Option for the Management of Refractory Inflammatory Bowel Disease

Giuseppe Privitera, Sara Onali, Daniela Pugliese et al. · Journal of Crohn s and Colitis · 2020 · 86 citations · Full text

, , +5

Impact of COVID‐19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high‐volume Italian inflammatory bowel disease centre

Franco Scaldaferri, Daniela Pugliese, Giuseppe Privitera et al. · United European Gastroenterology Journal · 2020 · 46 citations · Full text

, , +10

Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease

Luisa Guidi, Daniela Pugliese, Tommaso Panici Tonucci et al. · United European Gastroenterology Journal · 2019 · 42 citations · Full text

, , +15

Serum triiodothyronine‐to‐thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients

Lorenzo Bertani, Domenico Tricò, Daniela Pugliese et al. · Alimentary Pharmacology & Therapeutics · 2020 · 23 citations · Full text

, , +16

1–5 of 8